D.A. Davidson & Co’s Halozyme HALO Stock Holding History

D.A. Davidson & Co’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,944	Closed	-$281K	–	1371
2022 Q4	$281K	Buy	+4,944	New	+$253K	﹤0.01%	1076

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

D.A. Davidson & Co's HALO Position: Q1 2023 in Review

D.A. Davidson & Co sold out of Halozyme (HALO) in Q1 2023, closing a stake of 4,944 shares — an estimated $281K sold.

D.A. Davidson & Co first reported a position in HALO in Q4 2022 and held it in 1 quarter. The position peaked at $281K in Q4 2022. 386 funds tracked by Wall St. Rank hold HALO as of Q1 2023.

D.A. Davidson & Co reported no remaining Halozyme position as of Q1 2023 after selling out during the quarter.
D.A. Davidson & Co sold 4,944 Halozyme shares in Q1 2023, an estimated $281K.
D.A. Davidson & Co first reported a position in Halozyme in Q4 2022 and held it in 1 quarter.
D.A. Davidson & Co's Halozyme position peaked at $281K in Q4 2022.
386 funds tracked by Wall St. Rank held Halozyme as of Q1 2023.

Based on D.A. Davidson & Co's 13F filing for Q1 2023, filed 25 Apr 2023.